2019
DOI: 10.1159/000501214
|View full text |Cite
|
Sign up to set email alerts
|

Mindfulness-Based Cognitive Therapy Intervention for the Treatment of Late-Life Depression and Anxiety Symptoms in Primary Care: A Randomized Controlled Trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
21
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 19 publications
(22 citation statements)
references
References 6 publications
1
21
0
Order By: Relevance
“…We previously published an 8‐week assessor blind, two‐arm RCT of MBCT vs TAU for LLD and LLA (between September 2016 and October 2018) 5 . Before the trial began, ethics approval was granted by the Bureau d'examen de la recherche of the CIUSSS du Centre‐Ouest‐de‐l'Île‐de‐Montréal.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…We previously published an 8‐week assessor blind, two‐arm RCT of MBCT vs TAU for LLD and LLA (between September 2016 and October 2018) 5 . Before the trial began, ethics approval was granted by the Bureau d'examen de la recherche of the CIUSSS du Centre‐Ouest‐de‐l'Île‐de‐Montréal.…”
Section: Methodsmentioning
confidence: 99%
“…Eligible participants were ≥ 60 years old and had symptoms of depression and/or anxiety (score ≥10 on the patient health questionnaire [PHQ‐9] and/or General Anxiety Disorder 7‐Item Scale [GAD‐7]). Selected exclusion criteria included acute psychotic symptoms, severe personality disorder, and acute suicidal ideation/intent, and/or inability to communicate in either English or French 5 . Informed consent was obtained, and the privacy rights of the participants were maintained.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…While pharmacotherapy is frequently used to manage symptoms of anxiety in older adults, this approach has been related to negative side effects such as cardiovascular issues and falls [3,[19][20][21][22]. There is evidence in the research literature to suggest that older adults favor non-pharmacotherapy approaches, such as psychotherapy, but do not always have access to public mental health care, or can afford private mental health care [3,23]. Given the increased rates of anxiety due to COVID-19, there is an identified urgent need for evidence based alternatives to pharmacotherapy for the treatment of anxiety that are feasible, potentially scalable, and can be delivered at the primary care and community levels [23,24].…”
Section: Background and Rationalementioning
confidence: 99%
“…MBCT has demonstrated satisfactory treatment effects on reducing active depressive symptoms in younger adults. 25,26 However, studies of the efficacy of MBCT, particularly its immediacy effects, on older populations are limited, [27][28][29] presumably owing to differences in sample size and baseline depression levels from a mixture of sampling populations that ranged from those in remission to those currently depressed to those non-depressed with chronic back pain. Given that rumination and reduced AMS are potentially more prominent in depressed older adults, we aimed to examine the efficacy and cognitive mechanisms of MBCT in older adults with active depressive symptoms.…”
Section: Introductionmentioning
confidence: 99%